Saboor Ahmed Khan’s Post

Pakistan's pharmaceutical exports have shown impressive growth, registering a 31.11% rise in the first quarter of the financial year 2024-25 compared to the same period last year. Between July and September 2024, exports in this sector reached $105.936 million, a notable increase from $80.796 million during these months in 2023, according to data from the Pakistan Bureau of Statistics (PBS). In September 2024, the pharmaceutical industry saw an even more remarkable year-on-year surge of 61.55%, with export values reaching $43.607 million, up from $26.992 million in September 2023. The sector also demonstrated strong monthly growth, recording a 53.78% increase from $28.357 million in August 2024. This upward trend highlights the growing capabilities and global competitiveness of Pakistan's pharmaceutical sector. With these advancements, the industry is solidifying its place in the international market, furthering the recognition of Pakistani products worldwide. #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation

*Pakistan's Pharmaceutical Exports Soar: 31.11% Growth in Q1 2024-25!* Breaking News! Pakistan's pharmaceutical industry is making waves globally, recording a remarkable 31.11% increase in exports in the first quarter of FY 2024-25! Key Highlights: - $105.936 million in exports from July to September 2024, up from $80.796 million in 2023 - 61.55% year-on-year surge in September 2024, reaching $43.607 million - 53.78% month-on-month growth from August 2024 This impressive growth showcases Pakistan's expanding pharmaceutical capabilities and competitiveness on the global stage! *What's driving this success?* - Increased demand for quality generics - Growing international partnerships - Enhanced manufacturing capabilities - Government support for exports *Congratulations to Pakistan's pharmaceutical industry!* Let's discuss: - What opportunities arise from this growth? - How can we sustain this momentum? - What role can international collaborations play? Share your insights! #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation #GrowthStory #IndustryNews #TradeNews #BusinessUpdate #MarketWatch #Trends2024 #BusinessInsights #HealthcareSector #PakistanEconomy #ExportLedGrowth #PharmaceuticalManufacturing

Pharmaceutical exports from Pakistan have experienced remarkable growth, recording a 31.11% increase in the first quarter of the financial year 2024-25 compared to the same period last year. From July to September 2024, the exports reached $105.936 million, a substantial rise from $80.796 million during the same months in 2023, according to the Pakistan Bureau of Statistics (PBS). In September 2024, the sector witnessed a 61.55% surge year-on-year, with exports hitting $43.607 million, compared to $26.992 million in September 2023. Additionally, there was a 53.78% increase month-on-month from $28.357 million in August 2024. This growth reflects the expanding capabilities and competitiveness of Pakistan's pharmaceutical industry on the global stage. #PharmaceuticalExports #Pakistan #EconomicGrowth #ExportIncrease #HealthcareIndustry #PBS #FinancialYear2024 #MadeInPakistan #GlobalMarket #PharmaInnovation

The pharmaceutical industry is one of Bangladesh's most promising and knowledge-based sectors. However, the industry heavily imports raw materials from foreign sources, also known as active pharmaceutical ingredients (APIs). This makes the industry vulnerable to supply chain disruptions and price volatility. In this infographic, we have shown you the current scenario of LC opening for raw materials and exports of pharma products in Bangladesh. Share your thoughts in the comment below! #pharmaceuticalsindustry #LCOpening #BangladeshExports

With growing attention on #LocalManufacturing in the #PharmaceuticalIndustry in #Africa one critical piece in ensuring reliable and consistent production is a robust #SupplyChain system. This ranges from the coordination of #API vendor selection, qualification, procurement and coordination of supplies in line with production cycles. Beyond the manufacturing piece, there's a need to ensure produce gets to the market in a timely manner to the right market with predictable cycles that ensure consistent access. The African Pharmaceutical Network (APN) through the #PharmacyAcademy has invested in #WorkforceDevelopment with an offering in Pharmaceutical Supply Chain Management that will address these nuances ensuring local pharmaceutical players have reliable competent pool of professionals to work with in the continent. Enroll: https://lnkd.in/dSG4RGRU #AfricaWeWant #AfricaRising #PharmaIndustry

Pakistan's pharmaceutical exports have surged by 31% in the first three months of the current fiscal year, reaching $105.9 million, according to recent trade data. This significant growth highlights the expanding global demand for Pakistani pharmaceuticals, as well as the industry's focus on quality and compliance with international standards. Key export markets include Asia, Africa, and the Middle East, where demand for affordable, quality healthcare products is on the rise. This increase also reflects Pakistan's strategic investments in pharmaceutical production, quality control, and innovation, which have bolstered the country's standing in the global healthcare sector. The government’s efforts to support exporters with incentives and streamline regulatory processes have played a pivotal role in this upward trend, positioning Pakistan's pharmaceutical sector as a growing economic asset. Visit https://lnkd.in/dYepVRg8 to know more about us #PakistanPharmaceuticals #ExportGrowth #Healthcare #GlobalMarkets #EconomicDevelopment

India's pharma exports rise 10% to USD 27.9 bn in FY24 Experts have said that India's pharmaceutical business may exceed USD 130 billion by 2030, supported by expanding market opportunities and heightened demand in the overseas markets. The business stood at over USD 50 billion for the 2022-23. #IndiasPharmaExports | #IndiaPharmaceuticalBuisness | #Overseasmarket | #MarketOpportunities | #Healthnews Read more:

https://lnkd.in/d2HK5xW7 India's pharmaceutical sector stands at a crossroads. The journey toward self-reliance in API production is critical, not only for the stability of the industry but also for ensuring that India remains the world's "pharmacy" in both good times and bad.

From January to September 2024, China exported over 870 key pharmaceutical intermediates to India, with a total transaction value exceeding USD 1.75 billion. The top 30 products alone accounted for over USD 1.154 billion, reflecting a year-on-year decrease of 1.97%. Among these, 14 products saw a decline in transaction value, with the largest drop exceeding 50%, while the transaction value of 16 products increased year-on-year. The long-standing top product, 6-APA, had a transaction value of over USD 380 million. Additionally, five products recorded transaction values exceeding USD 50 million, and 20 products exceeded USD 10 million. Among the top 30 intermediate products, the transaction value of the Remimazolam intermediate (CAS 1289024-42-5) grew the fastest, increasing by over 317 times year-on-year, with quantities rising from kilogram-level to a 2-ton scale. #Intermediates #APIs #Rawmaterials #Pharma #Pharmaceuticalingredients